Domenico Ambrosio, MD, died last week at 88, according to Patch.
Pharmacy
Researchers at the Duke University Medical Center department of anesthesiology looked at factors that influence whether or not a person decides to participate in clinical anesthesia research, according to Anesthesia-Analgesia.
Merck's new drug application resubmission for sugammadex sodium injection has been accepted for review by the FDA.
Lenstec has announced the U.S. launch of its Softec HD Oval intraocular lens, according to a news release.
The Cincinnati Eye Institute plans to open its own compounding pharmacy, according to a Business Courtier report.
At a PAINWeek 2012 presentation investigators reported that immediate-release opioids are acceptable to use as supplemental analgesia in certain situations, according to the Monthly Prescribing Reference.
In a recent clinical trial, Pacira Pharmaceuticals found its drug EXPAREL reduced cumulative pain scores through 72 hours better than bupivacaine HCI.
Fairfield, Calif.-based NorthBay Healthcare purchased a cerebral oxygen monitoring device to help anesthesiologists read oxygen levels in the brain in real time during surgeries, according to The Reporter.
Nerve block anesthesia is gaining popularity as a safer alternative to general anesthesia, according to MedCity News.
FDA has announced it has approved Linzess (linaclotide) to treat chronic idiopathic constipation and to treat irritable bowel syndrome with constipation in adults, according to a news release.